Rönn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P, Tuomi T, Isomaa B, Groop L, Vaag A, Ling C
Department of Clinical Sciences, CRC Malmö University Hospital, Lund University, 205 02, Malmö, Sweden.
Diabetologia. 2008 Jul;51(7):1159-68. doi: 10.1007/s00125-008-1018-8. Epub 2008 May 17.
AIMS/HYPOTHESIS: Reduced oxidative capacity of the mitochondria in skeletal muscle has been suggested to contribute to insulin resistance and type 2 diabetes. Moreover, a set of genes influencing oxidative phosphorylation (OXPHOS) is downregulated in diabetic muscle. Here we studied whether genetic, epigenetic and non-genetic factors influence a component of the respiratory chain, COX7A1, previously shown to be downregulated in skeletal muscle from patients with type 2 diabetes. The specific aims were to: (1) evaluate the impact of genetic (single nucleotide polymorphisms [SNPs]), epigenetic (DNA methylation) and non-genetic (age) factors on the expression of COX7A1 in human skeletal muscle; and (2) investigate whether common variants in the COX7A1 gene are associated with increased risk of type 2 diabetes.
COX7A1 mRNA expression was analysed in muscle biopsies from young (n = 110) and elderly (n = 86) non-diabetic twins and related to measures of in vivo metabolism. Genetic variants (three SNPs) from the COX7A1 locus were genotyped in the twins and in two independent type 2 diabetes case-control cohorts (n = 1466 and 6380, respectively). DNA methylation of the COX7A1 promoter was analysed in a subset of twins (ten young, ten elderly) using bisulphite sequencing.
While DNA methylation of the COX7A1 promoter was increased in muscle from elderly compared with young twins (19.9 +/- 8.3% vs 1.8 +/- 2.7%; p = 0.035), the opposite was found for COX7A1 mRNA expression (elderly 1.00 +/- 0.05 vs young 1.68 +/- 0.06; p = 0.0005). The heritability of COX7A1 expression was estimated to be 50% in young and 72% in elderly twins. One of the polymorphisms investigated, rs753420, influenced basal COX7A1 expression in muscle of young (p = 0.0001) but not of elderly twins. The transcript level of COX7A1 was associated with increased in vivo glucose uptake and VO(2max) (p = 0.009 and p = 0.001, respectively). We did not observe any genetic association between COX7A1 polymorphisms and type 2 diabetes after correcting for multiple testing.
CONCLUSIONS/INTERPRETATION: Our results provide further evidence for age as a factor influencing DNA methylation and expression of OXPHOS genes, and thereby in vivo metabolism.
目的/假设:骨骼肌中线粒体氧化能力降低被认为与胰岛素抵抗和2型糖尿病有关。此外,一组影响氧化磷酸化(OXPHOS)的基因在糖尿病肌肉中表达下调。在此,我们研究了遗传、表观遗传和非遗传因素是否会影响呼吸链的一个组成部分COX7A1,此前研究表明该基因在2型糖尿病患者的骨骼肌中表达下调。具体目标如下:(1)评估遗传因素(单核苷酸多态性[SNPs])、表观遗传因素(DNA甲基化)和非遗传因素(年龄)对人骨骼肌中COX7A1表达的影响;(2)研究COX7A1基因中的常见变异是否与2型糖尿病风险增加相关。
分析了年轻(n = 110)和年长(n = 86)非糖尿病双胞胎肌肉活检样本中COX7A1 mRNA的表达,并将其与体内代谢指标相关联。在双胞胎以及两个独立的2型糖尿病病例对照队列(分别为n = 1466和6380)中对COX7A1基因座的遗传变异(三个SNP)进行基因分型。使用亚硫酸氢盐测序法分析了一部分双胞胎(十名年轻的、十名年长的)中COX7A1启动子的DNA甲基化情况。
与年轻双胞胎相比,年长双胞胎肌肉中COX7A1启动子的DNA甲基化增加(19.9 +/- 8.3% 对1.8 +/- 2.7%;p = 0.035),而COX7A1 mRNA表达情况则相反(年长的为1.00 +/- 0.05,年轻的为1.68 +/- 0.06;p = 0.0005)。估计年轻双胞胎中COX7A1表达的遗传度为50%,年长双胞胎中为72%。所研究的多态性之一rs753420影响年轻双胞胎肌肉中COX7A1的基础表达(p = 0.0001),但不影响年长双胞胎的。COX7A1的转录水平与体内葡萄糖摄取增加和最大摄氧量(VO₂max)相关(分别为p = 0.009和p = 0.001)。在进行多重检验校正后,我们未观察到COX7A1多态性与2型糖尿病之间存在任何遗传关联。
结论/解读:我们的结果进一步证明年龄是影响DNA甲基化和OXPHOS基因表达,进而影响体内代谢的一个因素。